This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguero-Rosenfeld, M E
Right arrow Articles by Wormser, G P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguero-Rosenfeld, M E
Right arrow Articles by Wormser, G P

 Previous Article  |  Next Article 

J Clin Microbiol. 1993 December; 31(12): 3090-3095

Serodiagnosis in early Lyme disease.

M E Aguero-Rosenfeld, J Nowakowski, D F McKenna, C A Carbonaro and G P Wormser

Department of Pathology, New York Medical College, Valhalla.

ABSTRACT

Using a commercially available enzyme-linked immunosorbent assay (ELISA) and an immunoblot assay (IB), we tested sera from 100 patients with erythema migrans (EM) seen in 1991 a the Westchester County Medical Center Lyme Disease Diagnostic Center. Convalescent-phase sera were available from 59 patients. Fifty-five patients had EM of < 7 days' duration, 31 had EM of 7 to 14 days' duration, and 14 had EM of > 14 days' duration. During the acute phase of infection, 35 patients had a positive ELISA result and 43 had a positive IB result by the recently published criteria of Dressler et al. (F. Dressler, J. A. Whalen, B. N. Reinhardt, and A. C. Steere, J. Infect. Dis. 167:392-400, 1993) for interpretation of IB in patients with Lyme disease. A greater sensitivity of IB was observed in patients with EM of < 7 days' duration, as follows: 14 of 55 (25%) for IB versus 7 of 55 (13%) for ELISA (P = 0.144). Sera of all 14 patients with EM of > 14 days' duration were reactive by both tests, as follows: 13 positive and 1 equivocal by ELISA and 12 positive and 2 indeterminate by the IB. The band reactivity most frequently observed in the IB was to the 41- and 25-kDa antigens, the latter being the most frequent band observed in immunoglobulin M blots. Seroconversion was observed in 74 and 64% of evaluable patients by ELISA and IB, respectively, despite the use of antibiotic therapy.

J Clin Microbiol. 1993 December; 31(12): 3090-3095




This article has been cited by other articles:

  • Coleman, A. S., Pal, U. (2009). BBK07, a Dominant In Vivo Antigen of Borrelia burgdorferi, Is a Potential Marker for Serodiagnosis of Lyme Disease. CVI 16: 1569-1575 [Abstract] [Full Text]  
  • Wormser, G. P., Nowakowski, J., Nadelman, R. B., Visintainer, P., Levin, A., Aguero-Rosenfeld, M. E. (2008). Impact of Clinical Variables on Borrelia burgdorferi-Specific Antibody Seropositivity in Acute-Phase Sera from Patients in North America with Culture-Confirmed Early Lyme Disease. CVI 15: 1519-1522 [Abstract] [Full Text]  
  • Hyde, J. A., Trzeciakowski, J. P., Skare, J. T. (2007). Borrelia burgdorferi Alters Its Gene Expression and Antigenic Profile in Response to CO2 Levels. J. Bacteriol. 189: 437-445 [Abstract] [Full Text]  
  • Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., Wormser, G. P. (2005). Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev. 18: 484-509 [Abstract] [Full Text]  
  • Lin, T., Oliver, J. H. Jr., Gao, L. (2002). Genetic Diversity of the Outer Surface Protein C Gene of Southern Borrelia Isolates and Its Possible Epidemiological, Clinical, and Pathogenetic Implications. J. Clin. Microbiol. 40: 2572-2583 [Abstract] [Full Text]  
  • Heikkila, T., Seppala, I., Saxen, H., Panelius, J., Peltomaa, M., Julin, T., Carlsson, S.-A., Lahdenne, P. (2002). Recombinant BBK32 Protein in Serodiagnosis of Early and Late Lyme Borreliosis. J. Clin. Microbiol. 40: 1174-1180 [Abstract] [Full Text]  
  • Sigal, L. H. (2002). Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen Terminology. ANN INTERN MED 136: 413-419 [Full Text]  
  • Ryan, R., Krause, P. J., Radolf, J., Freeman, K., Spielman, A., Lenz, R., Levin, A. (2001). Diagnosis of Babesiosis Using an Immunoblot Serologic Test. CVI 8: 1177-1180 [Abstract] [Full Text]  
  • Magnarelli, L. A., Ijdo, J. W., Padula, S. J., Flavell, R. A., Fikrig, E. (2000). Serologic Diagnosis of Lyme Borreliosis by Using Enzyme-Linked Immunosorbent Assays with Recombinant Antigens. J. Clin. Microbiol. 38: 1735-1739 [Abstract] [Full Text]  
  • Wormser, G. P., Bittker, S., Cooper, D., Nowakowski, J., Nadelman, R. B., Pavia, C. (2000). Comparison of the Yields of Blood Cultures Using Serum or Plasma from Patients with Early Lyme Disease. J. Clin. Microbiol. 38: 1648-1650 [Abstract] [Full Text]  
  • Strle, F., Nadelman, R. B., Cimperman, J., Nowakowski, J., Picken, R. N., Schwartz, I., Maraspin, V., Aguero-Rosenfeld, M. E., Varde, S., Lotric-Furlan, S., Wormser, G. P. (1999). Comparison of Culture-Confirmed Erythema Migrans Caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. ANN INTERN MED 130: 32-36 [Abstract] [Full Text]  
  • Mathiesen, M. J., Christiansen, M., Hansen, K., Holm, A., Åsbrink, E., Theisen, M. (1998). Peptide-Based OspC Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Lyme Borreliosis. J. Clin. Microbiol. 36: 3474-3479 [Abstract] [Full Text]  
  • Stevenson, B., Bono, J. L., Elias, A., Tilly, K., Rosa, P. (1998). Transformation of the Lyme Disease Spirochete Borrelia burgdorferi with Heterologous DNA. J. Bacteriol. 180: 4850-4855 [Abstract] [Full Text]  
  • Rauer, S., Spohn, N., Rasiah, C., Neubert, U., Vogt, A. (1998). Enzyme-Linked Immunosorbent Assay Using Recombinant OspC and the Internal 14-kDa Flagellin Fragment for Serodiagnosis of Early Lyme Disease. J. Clin. Microbiol. 36: 857-861 [Abstract] [Full Text]  
  • Brunner, M., Stein, S., Mitchell, P. D., Sigal, L. H. (1998). Immunoglobulin M Capture Assay for Serologic Confirmation of Early Lyme Disease: Analysis of Immune Complexes with Biotinylated Borrelia burgdorferi Sonicate Enhanced with Flagellin Peptide Epitope. J. Clin. Microbiol. 36: 1074-1080 [Abstract] [Full Text]  
  • Wormser, G., Nowakowski, J, Nadelman, R., Bittker, S, Cooper, D, Pavia, C (1998). Improving the yield of blood cultures for patients with early Lyme disease [In Process Citation]. J. Clin. Microbiol. 36: 296-298 [Abstract] [Full Text]  
  • Ellenbogen, C. (1997). Lyme Disease: Shift the Paradigm!. Arch Fam Med 6: 191-195 [Abstract]  
  • Gerber, M. A., Shapiro, E. D., Burke, G. S., Parcells, V. J., Bell, G. L., The Pediatric Lyme Disease Study Group, (1996). Lyme Disease in Children in Southeastern Connecticut. NEJM 335: 1270-1274 [Abstract] [Full Text]  
  • Sivak, S. L., Aguero-Rosenfeld, M. E., Nowakowski, J., Nadelman, R. B., Wormser, G. P. (1996). Accuracy of IgM Immunoblotting to Confirm the Clinical Diagnosis of Early Lyme Disease. Arch Intern Med 156: 2105-2109 [Abstract]  
  • Berglund, J., Eitrem, R., Ornstein, K., Lindberg, A., Ringner, A., Elmrud, H., Carlsson, M., Runehagen, A., Svanborg, C., Norrby, R. (1995). An Epidemiologic Study of Lyme Disease in Southern Sweden. NEJM 333: 1319-1324 [Abstract] [Full Text]  
  • O'Connell, S. (1995). Fortnightly review: Lyme disease in the United Kingdom. BMJ 310: 303-308 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»